Global Pancreatic Beta-Cell Protection Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 11-Jan-2021
No. of pages: 127
Inquire Before Buying

Pancreatic Beta-Cell Protection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pancreatic Beta-Cell Protection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Stem Cell Based

- Gene Therapies

- RNA Based Therapies

- Monoclonal Antibodies (MAbs)

- Phytotherapy

Segment by Application

- Hospital

- Medical Research Laboratory

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- ViaCyte

- PharmaCyte Biotech

- Boehringer Ingelheim

- GalaxoSmithKline

- Beta-Cell NV

- Novartis

- Janssen Research & Development

- Pfizer Inc

- BioLineRx

- GalaxoSmithKline

- Beta-Cell NV

- Sanofi

- Osiris Therapeutics

- Beta-O2 Technologies Ltd

Global Pancreatic Beta-Cell Protection Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Stem Cell Based
1.2.3 Gene Therapies
1.2.4 RNA Based Therapies
1.2.5 Monoclonal Antibodies (MAbs)
1.2.6 Phytotherapy
1.3 Market by Application
1.3.1 Global Pancreatic Beta-Cell Protection Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Medical Research Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pancreatic Beta-Cell Protection Market Perspective (2016-2027)
2.2 Pancreatic Beta-Cell Protection Growth Trends by Regions
2.2.1 Pancreatic Beta-Cell Protection Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pancreatic Beta-Cell Protection Historic Market Share by Regions (2016-2021)
2.2.3 Pancreatic Beta-Cell Protection Forecasted Market Size by Regions (2022-2027)
2.3 Pancreatic Beta-Cell Protection Industry Dynamic
2.3.1 Pancreatic Beta-Cell Protection Market Trends
2.3.2 Pancreatic Beta-Cell Protection Market Drivers
2.3.3 Pancreatic Beta-Cell Protection Market Challenges
2.3.4 Pancreatic Beta-Cell Protection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pancreatic Beta-Cell Protection Players by Revenue
3.1.1 Global Top Pancreatic Beta-Cell Protection Players by Revenue (2016-2021)
3.1.2 Global Pancreatic Beta-Cell Protection Revenue Market Share by Players (2016-2021)
3.2 Global Pancreatic Beta-Cell Protection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pancreatic Beta-Cell Protection Revenue
3.4 Global Pancreatic Beta-Cell Protection Market Concentration Ratio
3.4.1 Global Pancreatic Beta-Cell Protection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pancreatic Beta-Cell Protection Revenue in 2020
3.5 Pancreatic Beta-Cell Protection Key Players Head office and Area Served
3.6 Key Players Pancreatic Beta-Cell Protection Product Solution and Service
3.7 Date of Enter into Pancreatic Beta-Cell Protection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pancreatic Beta-Cell Protection Breakdown Data by Type
4.1 Global Pancreatic Beta-Cell Protection Historic Market Size by Type (2016-2021)
4.2 Global Pancreatic Beta-Cell Protection Forecasted Market Size by Type (2022-2027)
5 Pancreatic Beta-Cell Protection Breakdown Data by Application
5.1 Global Pancreatic Beta-Cell Protection Historic Market Size by Application (2016-2021)
5.2 Global Pancreatic Beta-Cell Protection Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pancreatic Beta-Cell Protection Market Size (2016-2027)
6.2 North America Pancreatic Beta-Cell Protection Market Size by Type
6.2.1 North America Pancreatic Beta-Cell Protection Market Size by Type (2016-2021)
6.2.2 North America Pancreatic Beta-Cell Protection Market Size by Type (2022-2027)
6.2.3 North America Pancreatic Beta-Cell Protection Market Size by Type (2016-2027)
6.3 North America Pancreatic Beta-Cell Protection Market Size by Application
6.3.1 North America Pancreatic Beta-Cell Protection Market Size by Application (2016-2021)
6.3.2 North America Pancreatic Beta-Cell Protection Market Size by Application (2022-2027)
6.3.3 North America Pancreatic Beta-Cell Protection Market Size by Application (2016-2027)
6.4 North America Pancreatic Beta-Cell Protection Market Size by Country
6.4.1 North America Pancreatic Beta-Cell Protection Market Size by Country (2016-2021)
6.4.2 North America Pancreatic Beta-Cell Protection Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pancreatic Beta-Cell Protection Market Size (2016-2027)
7.2 Europe Pancreatic Beta-Cell Protection Market Size by Type
7.2.1 Europe Pancreatic Beta-Cell Protection Market Size by Type (2016-2021)
7.2.2 Europe Pancreatic Beta-Cell Protection Market Size by Type (2022-2027)
7.2.3 Europe Pancreatic Beta-Cell Protection Market Size by Type (2016-2027)
7.3 Europe Pancreatic Beta-Cell Protection Market Size by Application
7.3.1 Europe Pancreatic Beta-Cell Protection Market Size by Application (2016-2021)
7.3.2 Europe Pancreatic Beta-Cell Protection Market Size by Application (2022-2027)
7.3.3 Europe Pancreatic Beta-Cell Protection Market Size by Application (2016-2027)
7.4 Europe Pancreatic Beta-Cell Protection Market Size by Country
7.4.1 Europe Pancreatic Beta-Cell Protection Market Size by Country (2016-2021)
7.4.2 Europe Pancreatic Beta-Cell Protection Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size (2016-2027)
8.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type
8.2.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type (2016-2027)
8.3 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application
8.3.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application (2016-2027)
8.4 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region
8.4.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pancreatic Beta-Cell Protection Market Size (2016-2027)
9.2 Latin America Pancreatic Beta-Cell Protection Market Size by Type
9.2.1 Latin America Pancreatic Beta-Cell Protection Market Size by Type (2016-2021)
9.2.2 Latin America Pancreatic Beta-Cell Protection Market Size by Type (2022-2027)
9.2.3 Latin America Pancreatic Beta-Cell Protection Market Size by Type (2016-2027)
9.3 Latin America Pancreatic Beta-Cell Protection Market Size by Application
9.3.1 Latin America Pancreatic Beta-Cell Protection Market Size by Application (2016-2021)
9.3.2 Latin America Pancreatic Beta-Cell Protection Market Size by Application (2022-2027)
9.3.3 Latin America Pancreatic Beta-Cell Protection Market Size by Application (2016-2027)
9.4 Latin America Pancreatic Beta-Cell Protection Market Size by Country
9.4.1 Latin America Pancreatic Beta-Cell Protection Market Size by Country (2016-2021)
9.4.2 Latin America Pancreatic Beta-Cell Protection Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size (2016-2027)
10.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type
10.2.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2016-2027)
10.3 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application
10.3.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2016-2027)
10.4 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country
10.4.1 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 ViaCyte
11.1.1 ViaCyte Company Details
11.1.2 ViaCyte Business Overview
11.1.3 ViaCyte Pancreatic Beta-Cell Protection Introduction
11.1.4 ViaCyte Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.1.5 ViaCyte Recent Development
11.2 PharmaCyte Biotech
11.2.1 PharmaCyte Biotech Company Details
11.2.2 PharmaCyte Biotech Business Overview
11.2.3 PharmaCyte Biotech Pancreatic Beta-Cell Protection Introduction
11.2.4 PharmaCyte Biotech Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.2.5 PharmaCyte Biotech Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Pancreatic Beta-Cell Protection Introduction
11.3.4 Boehringer Ingelheim Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.3.5 Boehringer Ingelheim Recent Development
11.4 GalaxoSmithKline
11.4.1 GalaxoSmithKline Company Details
11.4.2 GalaxoSmithKline Business Overview
11.4.3 GalaxoSmithKline Pancreatic Beta-Cell Protection Introduction
11.4.4 GalaxoSmithKline Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.4.5 GalaxoSmithKline Recent Development
11.5 Beta-Cell NV
11.5.1 Beta-Cell NV Company Details
11.5.2 Beta-Cell NV Business Overview
11.5.3 Beta-Cell NV Pancreatic Beta-Cell Protection Introduction
11.5.4 Beta-Cell NV Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.5.5 Beta-Cell NV Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Pancreatic Beta-Cell Protection Introduction
11.6.4 Novartis Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Janssen Research & Development
11.7.1 Janssen Research & Development Company Details
11.7.2 Janssen Research & Development Business Overview
11.7.3 Janssen Research & Development Pancreatic Beta-Cell Protection Introduction
11.7.4 Janssen Research & Development Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.7.5 Janssen Research & Development Recent Development
11.8 Pfizer Inc
11.8.1 Pfizer Inc Company Details
11.8.2 Pfizer Inc Business Overview
11.8.3 Pfizer Inc Pancreatic Beta-Cell Protection Introduction
11.8.4 Pfizer Inc Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.8.5 Pfizer Inc Recent Development
11.9 BioLineRx
11.9.1 BioLineRx Company Details
11.9.2 BioLineRx Business Overview
11.9.3 BioLineRx Pancreatic Beta-Cell Protection Introduction
11.9.4 BioLineRx Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.9.5 BioLineRx Recent Development
11.10 Genentech
11.10.1 Genentech Company Details
11.10.2 Genentech Business Overview
11.10.3 Genentech Pancreatic Beta-Cell Protection Introduction
11.10.4 Genentech Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.10.5 Genentech Recent Development
11.11 Novo Nordisk
11.11.1 Novo Nordisk Company Details
11.11.2 Novo Nordisk Business Overview
11.11.3 Novo Nordisk Pancreatic Beta-Cell Protection Introduction
11.11.4 Novo Nordisk Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.11.5 Novo Nordisk Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Pancreatic Beta-Cell Protection Introduction
11.12.4 Sanofi Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.12.5 Sanofi Recent Development
11.13 Osiris Therapeutics
11.13.1 Osiris Therapeutics Company Details
11.13.2 Osiris Therapeutics Business Overview
11.13.3 Osiris Therapeutics Pancreatic Beta-Cell Protection Introduction
11.13.4 Osiris Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.13.5 Osiris Therapeutics Recent Development
11.14 Beta-O2 Technologies Ltd
11.14.1 Beta-O2 Technologies Ltd Company Details
11.14.2 Beta-O2 Technologies Ltd Business Overview
11.14.3 Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Introduction
11.14.4 Beta-O2 Technologies Ltd Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.14.5 Beta-O2 Technologies Ltd Recent Development
11.15 Transition Therapeutics
11.15.1 Transition Therapeutics Company Details
11.15.2 Transition Therapeutics Business Overview
11.15.3 Transition Therapeutics Pancreatic Beta-Cell Protection Introduction
11.15.4 Transition Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2016-2021)
11.15.5 Transition Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Stem Cell Based
Table 3. Key Players of Gene Therapies
Table 4. Key Players of RNA Based Therapies
Table 5. Key Players of Monoclonal Antibodies (MAbs)
Table 6. Key Players of Phytotherapy
Table 7. Global Pancreatic Beta-Cell Protection Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Pancreatic Beta-Cell Protection Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Pancreatic Beta-Cell Protection Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Pancreatic Beta-Cell Protection Market Share by Regions (2016-2021)
Table 11. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Pancreatic Beta-Cell Protection Market Share by Regions (2022-2027)
Table 13. Pancreatic Beta-Cell Protection Market Trends
Table 14. Pancreatic Beta-Cell Protection Market Drivers
Table 15. Pancreatic Beta-Cell Protection Market Challenges
Table 16. Pancreatic Beta-Cell Protection Market Restraints
Table 17. Global Pancreatic Beta-Cell Protection Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Pancreatic Beta-Cell Protection Market Share by Players (2016-2021)
Table 19. Global Top Pancreatic Beta-Cell Protection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Beta-Cell Protection as of 2020)
Table 20. Ranking of Global Top Pancreatic Beta-Cell Protection Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Pancreatic Beta-Cell Protection Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pancreatic Beta-Cell Protection Product Solution and Service
Table 24. Date of Enter into Pancreatic Beta-Cell Protection Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2016-2021)
Table 28. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Pancreatic Beta-Cell Protection Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Pancreatic Beta-Cell Protection Revenue Market Share by Application (2016-2021)
Table 32. Global Pancreatic Beta-Cell Protection Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Pancreatic Beta-Cell Protection Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Pancreatic Beta-Cell Protection Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Pancreatic Beta-Cell Protection Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Pancreatic Beta-Cell Protection Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Pancreatic Beta-Cell Protection Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Pancreatic Beta-Cell Protection Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Pancreatic Beta-Cell Protection Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Pancreatic Beta-Cell Protection Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Pancreatic Beta-Cell Protection Market Size by Country (2022-2027) & (US$ Million)
Table 64. ViaCyte Company Details
Table 65. ViaCyte Business Overview
Table 66. ViaCyte Pancreatic Beta-Cell Protection Product
Table 67. ViaCyte Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 68. ViaCyte Recent Development
Table 69. PharmaCyte Biotech Company Details
Table 70. PharmaCyte Biotech Business Overview
Table 71. PharmaCyte Biotech Pancreatic Beta-Cell Protection Product
Table 72. PharmaCyte Biotech Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 73. PharmaCyte Biotech Recent Development
Table 74. Boehringer Ingelheim Company Details
Table 75. Boehringer Ingelheim Business Overview
Table 76. Boehringer Ingelheim Pancreatic Beta-Cell Protection Product
Table 77. Boehringer Ingelheim Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 78. Boehringer Ingelheim Recent Development
Table 79. GalaxoSmithKline Company Details
Table 80. GalaxoSmithKline Business Overview
Table 81. GalaxoSmithKline Pancreatic Beta-Cell Protection Product
Table 82. GalaxoSmithKline Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 83. GalaxoSmithKline Recent Development
Table 84. Beta-Cell NV Company Details
Table 85. Beta-Cell NV Business Overview
Table 86. Beta-Cell NV Pancreatic Beta-Cell Protection Product
Table 87. Beta-Cell NV Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 88. Beta-Cell NV Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Pancreatic Beta-Cell Protection Product
Table 92. Novartis Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Janssen Research & Development Company Details
Table 95. Janssen Research & Development Business Overview
Table 96. Janssen Research & Development Pancreatic Beta-Cell Protection Product
Table 97. Janssen Research & Development Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 98. Janssen Research & Development Recent Development
Table 99. Pfizer Inc Company Details
Table 100. Pfizer Inc Business Overview
Table 101. Pfizer Inc Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 102. Pfizer Inc Recent Development
Table 103. BioLineRx Company Details
Table 104. BioLineRx Business Overview
Table 105. BioLineRx Pancreatic Beta-Cell Protection Product
Table 106. BioLineRx Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 107. BioLineRx Recent Development
Table 108. Genentech Company Details
Table 109. Genentech Business Overview
Table 110. Genentech Pancreatic Beta-Cell Protection Product
Table 111. Genentech Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 112. Genentech Recent Development
Table 113. Novo Nordisk Company Details
Table 114. Novo Nordisk Business Overview
Table 115. Novo Nordisk Pancreatic Beta-Cell Protection Product
Table 116. Novo Nordisk Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 117. Novo Nordisk Recent Development
Table 118. Sanofi Company Details
Table 119. Sanofi Business Overview
Table 120. Sanofi Pancreatic Beta-Cell Protection Product
Table 121. Sanofi Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 122. Sanofi Recent Development
Table 123. Osiris Therapeutics Company Details
Table 124. Osiris Therapeutics Business Overview
Table 125. Osiris Therapeutics Pancreatic Beta-Cell Protection Product
Table 126. Osiris Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 127. Osiris Therapeutics Recent Development
Table 128. Beta-O2 Technologies Ltd Company Details
Table 129. Beta-O2 Technologies Ltd Business Overview
Table 130. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Product
Table 131. Beta-O2 Technologies Ltd Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 132. Beta-O2 Technologies Ltd Recent Development
Table 133. Transition Therapeutics Company Details
Table 134. Transition Therapeutics Business Overview
Table 135. Transition Therapeutics Pancreatic Beta-Cell Protection Product
Table 136. Transition Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2016-2021) & (US$ Million)
Table 137. Transition Therapeutics Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pancreatic Beta-Cell Protection Market Share by Type: 2020 VS 2027
Figure 2. Stem Cell Based Features
Figure 3. Gene Therapies Features
Figure 4. RNA Based Therapies Features
Figure 5. Monoclonal Antibodies (MAbs) Features
Figure 6. Phytotherapy Features
Figure 7. Global Pancreatic Beta-Cell Protection Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Medical Research Laboratory Case Studies
Figure 10. Others Case Studies
Figure 11. Pancreatic Beta-Cell Protection Report Years Considered
Figure 12. Global Pancreatic Beta-Cell Protection Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Pancreatic Beta-Cell Protection Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Pancreatic Beta-Cell Protection Market Share by Regions: 2020 VS 2027
Figure 15. Global Pancreatic Beta-Cell Protection Market Share by Regions (2022-2027)
Figure 16. Global Pancreatic Beta-Cell Protection Market Share by Players in 2020
Figure 17. Global Top Pancreatic Beta-Cell Protection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pancreatic Beta-Cell Protection as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Pancreatic Beta-Cell Protection Revenue in 2020
Figure 19. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2016-2021)
Figure 20. Global Pancreatic Beta-Cell Protection Revenue Market Share by Type (2022-2027)
Figure 21. North America Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Pancreatic Beta-Cell Protection Market Share by Type (2016-2027)
Figure 23. North America Pancreatic Beta-Cell Protection Market Share by Application (2016-2027)
Figure 24. North America Pancreatic Beta-Cell Protection Market Share by Country (2016-2027)
Figure 25. United States Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Pancreatic Beta-Cell Protection Market Share by Type (2016-2027)
Figure 29. Europe Pancreatic Beta-Cell Protection Market Share by Application (2016-2027)
Figure 30. Europe Pancreatic Beta-Cell Protection Market Share by Country (2016-2027)
Figure 31. Germany Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Pancreatic Beta-Cell Protection Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Pancreatic Beta-Cell Protection Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Pancreatic Beta-Cell Protection Market Share by Region (2016-2027)
Figure 41. China Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Pancreatic Beta-Cell Protection Market Share by Type (2016-2027)
Figure 49. Latin America Pancreatic Beta-Cell Protection Market Share by Application (2016-2027)
Figure 50. Latin America Pancreatic Beta-Cell Protection Market Share by Country (2016-2027)
Figure 51. Mexico Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Pancreatic Beta-Cell Protection Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Pancreatic Beta-Cell Protection Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Pancreatic Beta-Cell Protection Market Share by Country (2016-2027)
Figure 57. Turkey Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Pancreatic Beta-Cell Protection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. ViaCyte Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 61. PharmaCyte Biotech Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 63. GalaxoSmithKline Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 64. Beta-Cell NV Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 66. Janssen Research & Development Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 67. Pfizer Inc Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 68. BioLineRx Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 69. Genentech Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 70. Novo Nordisk Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 71. Sanofi Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 72. Osiris Therapeutics Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 73. Beta-O2 Technologies Ltd Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 74. Transition Therapeutics Revenue Growth Rate in Pancreatic Beta-Cell Protection Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
  • Global Centralized Patient Monitoring System Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 130
    According to this latest study, the 2020 growth of Centralized Patient Monitoring System will have significant change from previous year. By the most conservative estimates of global Centralized Patient Monitoring System market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 490.5 million in 2019. Over the next five years the Centralized Patient Monitoring System market will register a 6.3% CAGR in terms of revenue, the global market size will rea......
  • Global Livestock Animal Vaccines Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 159
    According to this latest study, the 2020 growth of Livestock Animal Vaccines will have significant change from previous year. By the most conservative estimates of global Livestock Animal Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 4632.4 million in 2019. Over the next five years the Livestock Animal Vaccines market will register a 6.1% CAGR in terms of revenue, the global market size will reach US$ 5868.7 million by 2025.......
  • Global Clinical Reference Laboratory Services Market Growth (Status and Outlook) 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 132
    According to this latest study, the 2020 growth of Clinical Reference Laboratory Services will have significant change from previous year. By the most conservative estimates of global Clinical Reference Laboratory Services market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 11450 million in 2019. Over the next five years the Clinical Reference Laboratory Services market will register a 5.4% CAGR in terms of revenue, the global market size will ......
  • Global Steam Chemical Indicator Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 139
    According to this latest study, the 2020 growth of Steam Chemical Indicator will have significant change from previous year. By the most conservative estimates of global Steam Chemical Indicator market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 105.9 million in 2019. Over the next five years the Steam Chemical Indicator market will register a 6.7% CAGR in terms of revenue, the global market size will reach US$ 137.2 million by 2025. ......
  • Global Oral Guided Bone Regeneration (GTR) Membrane Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 167
    According to this latest study, the 2020 growth of Oral Guided Bone Regeneration (GTR) Membrane will have significant change from previous year. By the most conservative estimates of global Oral Guided Bone Regeneration (GTR) Membrane market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 201.6 million in 2019. Over the next five years the Oral Guided Bone Regeneration (GTR) Membrane market will register a 6.6% CAGR in terms of revenue, the global......
  • Global Non-Wearable Sleep Tracker Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 137
    According to this latest study, the 2020 growth of Non-Wearable Sleep Tracker will have significant change from previous year. By the most conservative estimates of global Non-Wearable Sleep Tracker market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 250.4 million in 2019. Over the next five years the Non-Wearable Sleep Tracker market will register a 13.7% CAGR in terms of revenue, the global market size will reach US$ 418.6 million by 2025.......
  • Global Hematopoietic Stem Cells Transplantation Market Growth (Status and Outlook) 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 119
    According to this latest study, the 2020 growth of Hematopoietic Stem Cells Transplantation will have significant change from previous year. By the most conservative estimates of global Hematopoietic Stem Cells Transplantation market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 2110.6 million in 2019. Over the next five years the Hematopoietic Stem Cells Transplantation market will register a 5.9% CAGR in terms of revenue, the global market siz......
  • Global Non-invasive Glucose Monitoring Device Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 132
    According to this latest study, the 2020 growth of Non-invasive Glucose Monitoring Device will have significant change from previous year. By the most conservative estimates of global Non-invasive Glucose Monitoring Device market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 2974.9 million in 2019. Over the next five years the Non-invasive Glucose Monitoring Device market will register a 26.7% CAGR in terms of revenue, the global market size wil......
  • Global Veterinary Rapid Test Market Growth (Status and Outlook) 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 131
    According to this latest study, the 2020 growth of Veterinary Rapid Test will have significant change from previous year. By the most conservative estimates of global Veterinary Rapid Test market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 493.7 million in 2019. Over the next five years the Veterinary Rapid Test market will register a 8.8% CAGR in terms of revenue, the global market size will reach US$ 692.3 million by 2025. Thi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs